-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- How much did that dead bird weigh? in Work In Progress
- Ancient DNA Gets Older and Multiple Births Get Bigger in Work In Progress
- Nine Lessons and Carols in Communicating Climate Uncertainty in Work In Progress
- How a Free Trade Agreement Threatens Your Health and the Health of the People You Care About in Work In Progress
- PLOS Biology at ASCB 2013: Open for Cell Biology in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Industry’s Influence
Category: Drug Development, Housekeeping, Industry funding
Tagged Aaron Kesselheim, bondaglutaraz, clinical trials, drug development, Jeffrey Drazen, New England Journal of Medicine, NIH, pharmaceutical industry
Comments Off
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.